102 related articles for article (PubMed ID: 28905400)
21. ACSL4 promotes prostate cancer growth, invasion and hormonal resistance.
Wu X; Deng F; Li Y; Daniels G; Du X; Ren Q; Wang J; Wang LH; Yang Y; Zhang V; Zhang D; Ye F; Melamed J; Monaco ME; Lee P
Oncotarget; 2015 Dec; 6(42):44849-63. PubMed ID: 26636648
[TBL] [Abstract][Full Text] [Related]
22. Androgens induce a distinct response of epithelial-mesenchymal transition factors in human prostate cancer cells.
Colditz J; Rupf B; Maiwald C; Baniahmad A
Mol Cell Biochem; 2016 Oct; 421(1-2):139-47. PubMed ID: 27562825
[TBL] [Abstract][Full Text] [Related]
23. Unleashing the Diagnostic, Prognostic and Therapeutic Potential of the Neuronostatin/GPR107 System in Prostate Cancer.
Sáez-Martínez P; Jiménez-Vacas JM; León-González AJ; Herrero-Aguayo V; Montero Hidalgo AJ; Gómez-Gómez E; Sánchez-Sánchez R; Requena-Tapia MJ; Castaño JP; Gahete MD; Luque RM
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32498336
[TBL] [Abstract][Full Text] [Related]
24. Novel long non-coding RNAs are specific diagnostic and prognostic markers for prostate cancer.
Böttcher R; Hoogland AM; Dits N; Verhoef EI; Kweldam C; Waranecki P; Bangma CH; van Leenders GJ; Jenster G
Oncotarget; 2015 Feb; 6(6):4036-50. PubMed ID: 25686826
[TBL] [Abstract][Full Text] [Related]
25. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.
Fuse M; Kojima S; Enokida H; Chiyomaru T; Yoshino H; Nohata N; Kinoshita T; Sakamoto S; Naya Y; Nakagawa M; Ichikawa T; Seki N
J Hum Genet; 2012 Nov; 57(11):691-9. PubMed ID: 22854542
[TBL] [Abstract][Full Text] [Related]
26. Complex impacts of PI3K/AKT inhibitors to androgen receptor gene expression in prostate cancer cells.
Liu L; Dong X
PLoS One; 2014; 9(10):e108780. PubMed ID: 25360799
[TBL] [Abstract][Full Text] [Related]
27. Direct regulation of LAMP1 by tumor-suppressive microRNA-320a in prostate cancer.
Okato A; Goto Y; Kurozumi A; Kato M; Kojima S; Matsushita R; Yonemori M; Miyamoto K; Ichikawa T; Seki N
Int J Oncol; 2016 Jul; 49(1):111-22. PubMed ID: 27212625
[TBL] [Abstract][Full Text] [Related]
28. Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer.
Crea F; Watahiki A; Quagliata L; Xue H; Pikor L; Parolia A; Wang Y; Lin D; Lam WL; Farrar WL; Isogai T; Morant R; Castori-Eppenberger S; Chi KN; Wang Y; Helgason CD
Oncotarget; 2014 Feb; 5(3):764-74. PubMed ID: 24519926
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of androgen receptors by NaAsO
Kim Y; Park SE; Moon JW; Kim BM; Kim HG; Jeong IG; Yoo S; Ahn JB; You D; Pak JH; Kim S; Hwang JJ; Kim CS
Prostate; 2017 Jul; 77(10):1128-1136. PubMed ID: 28556958
[TBL] [Abstract][Full Text] [Related]
30. Androgen Receptor Coactivators in Regulation of Growth and Differentiation in Prostate Cancer.
Culig Z
J Cell Physiol; 2016 Feb; 231(2):270-4. PubMed ID: 26201947
[TBL] [Abstract][Full Text] [Related]
31. HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgen-independent cancer.
Montironi R; Mazzucchelli R; Barbisan F; Stramazzotti D; Santinelli A; Scarpelli M; Lòpez Beltran A
Hum Pathol; 2006 Sep; 37(9):1137-44. PubMed ID: 16938518
[TBL] [Abstract][Full Text] [Related]
32. Identification of an anabolic selective androgen receptor modulator that actively induces death of androgen-independent prostate cancer cells.
Schmidt A; Meissner RS; Gentile MA; Chisamore MJ; Opas EE; Scafonas A; Cusick TE; Gambone C; Pennypacker B; Hodor P; Perkins JJ; Bai C; Ferraro D; Bettoun DJ; Wilkinson HA; Alves SE; Flores O; Ray WJ
J Steroid Biochem Mol Biol; 2014 Sep; 143():29-39. PubMed ID: 24565564
[TBL] [Abstract][Full Text] [Related]
33. KLF9, a transcription factor induced in flutamide-caused cell apoptosis, inhibits AKT activation and suppresses tumor growth of prostate cancer cells.
Shen P; Sun J; Xu G; Zhang L; Yang Z; Xia S; Wang Y; Liu Y; Shi G
Prostate; 2014 Jun; 74(9):946-58. PubMed ID: 24737412
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical expression and localization of somatostatin receptor subtypes in prostate cancer with neuroendocrine differentiation.
Morichetti D; Mazzucchelli R; Santinelli A; Stramazzotti D; Lopez-Beltran A; Scarpelli M; Bono AV; Cheng L; Montironi R
Int J Immunopathol Pharmacol; 2010; 23(2):511-22. PubMed ID: 20646346
[TBL] [Abstract][Full Text] [Related]
35. Somatostatin receptor types 1 and 2 in the developing mammalian cochlea.
Bodmer D; Brand Y; Radojevic V
Dev Neurosci; 2012; 34(4):342-53. PubMed ID: 22986312
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis.
Cha YJ; Lee JH; Han HH; Kim BG; Kang S; Choi YD; Cho NH
Prostate; 2016 Jul; 76(10):937-47. PubMed ID: 27017949
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of miR-195 promotes prostate cancer progression by targeting HMGA1.
Zhang X; Tao T; Liu C; Guan H; Huang Y; Xu B; Chen M
Oncol Rep; 2016 Jul; 36(1):376-82. PubMed ID: 27175617
[TBL] [Abstract][Full Text] [Related]
38. Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancer.
Jiménez-Vacas JM; Herrero-Aguayo V; Gómez-Gómez E; León-González AJ; Sáez-Martínez P; Alors-Pérez E; Fuentes-Fayos AC; Martínez-López A; Sánchez-Sánchez R; González-Serrano T; López-Ruiz DJ; Requena-Tapia MJ; Castaño JP; Gahete MD; Luque RM
Transl Res; 2019 Oct; 212():89-103. PubMed ID: 31344348
[TBL] [Abstract][Full Text] [Related]
39. MiR-1247-5p is overexpressed in castration resistant prostate cancer and targets MYCBP2.
Scaravilli M; Porkka KP; Brofeldt A; Annala M; Tammela TL; Jenster GW; Nykter M; Visakorpi T
Prostate; 2015 Jun; 75(8):798-805. PubMed ID: 25731699
[TBL] [Abstract][Full Text] [Related]
40. Hydrazinobenzoylcurcumin inhibits androgen receptor activity and growth of castration-resistant prostate cancer in mice.
Wu M; Kim SH; Datta I; Levin A; Dyson G; Li J; Kaypee S; Swamy MM; Gupta N; Kwon HJ; Menon M; Kundu TK; Reddy GP
Oncotarget; 2015 Mar; 6(8):6136-50. PubMed ID: 25704883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
